We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187M
AUM Growth
-$27.2M
Cap. Flow
-$38M
Cap. Flow %
-20.28%
Top 10 Hldgs %
43.93%
Holding
89
New
25
Increased
12
Reduced
22
Closed
25

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$5.07M
2
GILD icon
Gilead Sciences
GILD
+$4.16M
3
DXCM icon
DexCom
DXCM
+$2.66M
4
ETRM
EnteroMedics Inc.
ETRM
+$2.43M
5
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$2.39M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$4.51M
2
MRK icon
Merck
MRK
+$3.97M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.91M
4
STJ
St Jude Medical
STJ
+$3.64M
5
PBYI icon
Puma Biotechnology
PBYI
+$3.59M

Sector Composition

Rank Sector Weight
1 Healthcare 70.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVNR
26
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$2.68M 1.43%
225,000
-25,000
-10% -$171K
DXCM icon
27
DexCom
DXCM
$33.8B
$2.6M 1.39%
+260,000
New +$2.66M
WMGI
28
DELISTED
Wright Medical Group Inc
WMGI
$2.58M 1.38%
85,000
– –
ALKS icon
29
Alkermes
ALKS
$8.26B
$2.57M 1.37%
60,000
-25,000
-29% -$1.12M
THC icon
30
Tenet Healthcare
THC
$20.9B
$2.52M 1.35%
42,500
-42,500
-50% -$2.37M
AMGN icon
31
CALL
Amgen
AMGN
$224B
$2.46M 1.31%
17,500
-7,500
-30% -$979K
PBYI icon
32
Puma Biotechnology
PBYI
$453M
$2.39M 1.27%
10,000
-17,500
-64% -$3.59M
MRK icon
33
PUT
Merck
MRK
$322B
$2.37M 1.27%
+41,920
New +$2.35M
SLXP
34
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$2.34M 1.25%
15,000
-12,500
-45% -$1.81M
ASPX
35
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$2.31M 1.23%
+90,000
New +$1.91M
CMRX
36
DELISTED
Chimerix, Inc.
CMRX
$2.07M 1.11%
+75,000
New +$1.82M
CLDX icon
37
Celldex Therapeutics
CLDX
$3.48B
$1.94M 1.04%
10,000
-4,000
-29% -$872K
ELGX
38
DELISTED
Endologix Inc
ELGX
$1.94M 1.03%
18,250
-1,250
-6% -$174K
DYAX
39
DELISTED
DYAX CORPORATION
DYAX
$1.87M 1%
185,000
+67,500
+57% +$654K
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$13.5B
$1.8M 0.96%
25,000
-7,500
-23% -$493K
AGN
41
DELISTED
Allergan Inc
AGN
$1.78M 0.95%
+10,000
New +$1.66M
LJPC
42
DELISTED
La Jolla Pharmaceutical Company
LJPC
$1.73M 0.92%
180,000
+80,000
+80% +$796K
NVDQ
43
DELISTED
Novadaq Technologies Inc.
NVDQ
$1.59M 0.85%
125,000
+5,000
+4% +$72.8K
PETX
44
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.51M 0.8%
+150,000
New +$1.82M
ARWR icon
45
Arrowhead Research
ARWR
$12.6B
$1.33M 0.71%
+90,000
New +$1.23M
OSUR icon
46
OraSure Technologies
OSUR
$268M
$1.26M 0.68%
+175,000
New +$1.4M
ELOS
47
DELISTED
Syneron Medical Ltd
ELOS
$1.2M 0.64%
+120,000
New +$1.22M
IPXL
48
DELISTED
Impax Laboratories, Inc.
IPXL
$1.19M 0.63%
50,000
-25,000
-33% -$640K
CLDX icon
49
CALL
Celldex Therapeutics
CLDX
$3.48B
$972K 0.52%
+5,000
New +$1.09M
FLXN
50
DELISTED
Flexion Therapeutics, Inc.
FLXN
$913K 0.49%
50,000
– –
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2014 Portfolio in Review

As of Q3 2014, Iguana Healthcare Management held 89 positions worth $187M, down 13% from $214M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Iguana Healthcare Management withdrew a net $38M in Q3 2014, closing 25 positions and reducing 22 holdings. Its most notable exit was HCA Healthcare, an estimated $4.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 67% a quarter earlier.

Against the trend, Iguana Healthcare Management opened a new position in Zimmer Biomet worth $5.03M.

  • Iguana Healthcare Management's largest Q3 2014 buy was Zimmer Biomet: 51,500 shares worth $5.03M.
  • Iguana Healthcare Management added most to Gilead Sciences in Q3 2014, an estimated $4.16M increase.
  • Iguana Healthcare Management's biggest Q3 2014 reduction was Merck, cutting an estimated $3.97M.
  • Iguana Healthcare Management fully exited HCA Healthcare in Q3 2014, selling an estimated $4.51M.
  • Iguana Healthcare Management's ten largest holdings make up 44% of its $187M portfolio in Q3 2014.
  • Iguana Healthcare Management opened 25 new positions and closed 25 in Q3 2014.
  • Iguana Healthcare Management's portfolio value fell 13% quarter-over-quarter to $187M.

Based on Iguana Healthcare Management's 13F filing for Q3 2014, filed 14 Nov 2014.